Evaluation of the EQ-5D-3L and 5L versions in low back pain patients
Open Access
- 28 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Health and Quality of Life Outcomes
- Vol. 19 (1), 1-9
- https://doi.org/10.1186/s12955-021-01792-y
Abstract
The EuroQol EQ-5D is one of the most widely researched and applied patient-reported outcome measures worldwide. The original EQ-5D-3L and more recent EQ-5D-5L include three and five response categories respectively. Evidence from healthy and sick populations shows that the additional two response categories improve measurement properties but there has not been a concurrent comparison of the two versions in patients with low back pain (LBP). LBP patients taking part in a multicenter randomized controlled trial of lumbar total disc replacement and conservative treatment completed the EQ-5D-3L and 5L in an eight-year follow-up questionnaire. The 3L and 5L were assessed for aspects of data quality including missing data, floor and ceiling effects, response consistency, and based on a priori hypotheses, associations with the Oswestry Disability Index (ODI), Pain-Visual Analogue Scales and Hopkins Symptom Checklist (HSCL-25). At the eight-year follow-up, 151 (87%) patients were available and 146 completed both the 3L and 5L. Levels of missing data were the same for the two versions. Compared to the EQ-5D-5L, the 3L had significantly higher floor (pain discomfort) and ceiling effects (mobility, self-care, pain/discomfort, anxiety/depression). For these patients the EQ-5D-5L described 73 health states compared to 28 for the 3L. Shannon’s indices showed the 5L outperformed the 3L in tests of classification efficiency. Correlations with the ODI, Pain-VAS and HSCL-25 were largely as hypothesized, the 5L having slightly higher correlations than the 3L. The EQ-5D assesses important aspect of health in LBP patients and the 5L improves upon the 3L in this respect. The EQ-5D-5L is recommended in preference to the 3L version, however, further testing in other back pain populations together with additional measurement properties, including responsiveness to change, is recommended. Trial registration: retrospectively registered: https://clinicaltrials.gov/ct2/show/NCT01704677.Keywords
Funding Information
- Norges Forskningsrå (262673)
- Oslo University Hospital
- EkstraStiftelsen Helse og Rehabilitering
This publication has 41 references indexed in Scilit:
- A proposed set of metrics for standardized outcome reporting in the management of low back painActa Orthopaedica, 2015
- Assessing the performance of the EQ-VAS in the NHS PROMs programmeQuality of Life Research, 2013
- Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc diseaseBMC Musculoskeletal Disorders, 2013
- Can we define success criteria for lumbar disc surgery?Acta Orthopaedica, 2013
- Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value SetsValue in Health, 2012
- Cost-effectiveness of conservative treatments for neck pain: a systematic review on economic evaluationsEuropean Spine Journal, 2012
- Surgery with disc prosthesis versus rehabilitation in patients with low back pain and degenerative disc: two year follow-up of randomised studyBMJ, 2011
- Health-related quality of life assessment by the EuroQol-5D can provide cost-utility data in the field of low-back surgery.European Spine Journal, 2005
- CROSS-CULTURAL ADAPTATION OF THE NORWEGIAN VERSIONS OF THE ROLAND-MORRIS DISABILITY QUESTIONNAIRE AND THE OSWESTRY DISABILITY INDEXJournal of Rehabilitation Medicine, 2003
- The Hopkins Symptom Checklist (HSCL): A self-report symptom inventoryBehavioral Science, 1974